524632 — Shukra Pharmaceuticals Share Price
Last trade - 00:00- IN₹179.09m
- IN₹26.00m
- IN₹745.73m
- 29
- 70
- 90
- 72
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.35 | ||
| Price to Tang. Book | 0.35 | ||
| Price to Free Cashflow | 1.59 | ||
| Price to Sales | 0.62 | ||
| EV to EBITDA | 0.36 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 12.11% | ||
| Return on Equity | 16.6% | ||
| Operating Margin | 24.06% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 118.46 | 111.96 | 204.86 | 588.34 | 745.73 | n/a | n/a | 67.48% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | -76.19 | +2527.67 | -35.4 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Shukra Pharmaceuticals Limited is an India-based pharmaceutical company engaged in developing, manufacturing and marketing a range of pharmaceutical products globally and domestically. The Company’s product portfolio consists of tablet and capsules (general) solid oral dosage form and small volume parenteral- liquid injection vial and ampules. The Company’s products include Losartan Potassium Tablets USP 50 mg, Glimepiride Tablets USP 2 mg, Pantoprazole Tablets USP 40 mg, Methocarbamol Tablets USP 500 mg, Omeprazole Capsule IP 20 mg, Amlodipine besylate Tablets USP 5 mg, Ranitidine Tablets USP 150 mg, Ranitidine Tablets USP 300 mg, Ciprofloxacin Tablets USP 250 mg, Ciprofloxacin Tablets USP 500 mg, Atorvastatin Tablets USP 10mg, Sildenafil citrate Tablets BP 100 mg, Diclofenac Sodium Tablets BP 50 mg, Mebendazole Tablets USP 100 mg, Paracetamol Tablets BP 500 mg, Artemether 80 mg and Lumefantrine 480 mg Tablets, Clotrimazole Vaginal Tablets 100 mg and others.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 4th, 1993
- Public Since
- July 18th, 1994
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 10,946,986
- Address
- Veer House, 3rd Floor, Judges Bungalow R, AHMEDABAD, 380054
- Web
- http://www.shukrapharmaceuticals.com/
- Phone
- +91 9099961408
- Auditors
- Maak and Associates
Upcoming Events for 524632
Similar to 524632
Aayush Wellness
Bombay Stock Exchange
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
FAQ
As of Today at 23:15 UTC, shares in Shukra Pharmaceuticals are trading at IN₹17.22. This share price information is delayed by 15 minutes.
Shares in Shukra Pharmaceuticals last closed at IN₹17.22 and the price had moved by +87.99% over the past 365 days. In terms of relative price strength the Shukra Pharmaceuticals share price has outperformed the S&P BSE 100 Index by +77.09% over the past year.
There is no consensus recommendation for this security.
Find out moreThe Shukra Pharmaceuticals dividend yield is 0.58% based on the trailing twelve month period.
Last year, Shukra Pharmaceuticals paid a total dividend of IN₹0.10, and it currently has a trailing dividend yield of 0.58%. We do not have any data on when Shukra Pharmaceuticals is to next pay dividends.
We do not have data on when Shukra Pharmaceuticals is to next pay dividends. The historic dividend yield on Shukra Pharmaceuticals shares is currently 0.58%.
To buy shares in Shukra Pharmaceuticals you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹17.22, shares in Shukra Pharmaceuticals had a market capitalisation of IN₹179.09m.
Here are the trading details for Shukra Pharmaceuticals:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 524632
Based on an overall assessment of its quality, value and momentum Shukra Pharmaceuticals is currently classified as a Turnaround. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Shukra Pharmaceuticals. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +173.31%.
As of the last closing price of IN₹17.22, shares in Shukra Pharmaceuticals were trading +34.84% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Shukra Pharmaceuticals PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹17.22.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Shukra Pharmaceuticals' directors